Develops programmable cell therapies for cancer patients.
You can scroll over the chart's area to move in time and tap to see a specific date.
Highest Bid
$ 260.80
Lowest Offer
$ 188.50
Last Trade
$ 234.00
Live Orders
1,298
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
ArsenalBio is building a programmable cell therapy company to create highly effective and accessible immune cell therapies to impact outcomes for a much broader number of patients, initially those with cancer. ArsenalBio is focused on integrating technologies such as CRISPR-based genome engineering, scaled and high throughput target identification, synthetic biology, and machine learning to advance a new paradigm to discover and develop in immune cell therapies. With its programmable and computationally driven approach, ArsenalBio aspires to evolve critical metrics of success for immune cell therapies, including enhanced and broader efficacy, increased patient safety, reduced provider costs, and expanded market access.
ArsenalBio Funding
Sign up to gain insights into ArsenalBio funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series C | Jul 09, 2024 | 298M | ||
| Series B | May 31, 2022 | 89M | ||
| Series B | Feb 10, 2022 | 99M | ||
| Series B | Dec 14, 2020 | 33M | ||
| Series A | Oct 17, 2019 | 85M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
ArsenalBio Management Team
Investors
Bristol-Myers Squibb Company
Byers Capital
Emerson Collective
Euclidean Capital
Green Sands Equity
Hitachi
Kleiner Perkins Caufield & Byers
Osage Partners
Sixth Street Partners
SoftBank
The Parker Institute for Cancer Immunotherapy
UCSF Foundation Investment Company
Waycross Ventures
Westlake Village BioPartners
ArsenalBio Valuations & Financials
View real-time NPM data on ArsenalBio stock including daily ArsenalBio stock price estimates, valuation history, and historical share price information. Access ArsenalBio financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track ArsenalBio pricing across six independent market signals. Looking for private company due diligence data sources on ArsenalBio? Get in touch to learn more.
Similar Companies
like ArsenalBio
Inari Agriculture
Health Care
Uses AI-powered predictive design and gene editing to create sustainable, nature-positive seeds for a more efficient food system.
Rakuten Medical
Health Care
Develops targeted cancer treatments using photoimmunotherapy technology to create more effective and accessible therapeutic solutions.
OpenTrons
Industrials
A developer of a pipetting robot technology designed to automate experiments.
FAQ
We have answers
ArsenalBio stock does not trade on public stock exchanges. ArsenalBio stock is considered a private security and you need to be an accredited investor to trade shares. To invest in ArsenalBio stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
ArsenalBio Stock does not trade on public stock exchanges. In order to sell ArsenalBio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Nasdaq Private Market estimates that ArsenalBio price per share was $14.48 as of May 14, 2026. This ArsenalBio share value estimate (known as the NPM price) is based on market activity, publicly-sourced valuation data, and other proprietary information. With NPM Data and Intelligence premium for investors, you can get visibility into the ArsenalBio share price today and the factors driving ArsenalBio valuation estimates. Learn more about premium data here.
Read more about private company stock prices: Understanding the Bid-Ask Spread: How Buyers and Sellers Match on Price
There is no ticker symbol for ArsenalBio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell ArsenalBio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in ArsenalBio stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
ArsenalBio is a private company and has not had an IPO. There is currently no ArsenalBio IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to ArsenalBio IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
